The Impact of Big Data on Chronic Disease Management by Bhardwaj, Niharika et al.
Marshall University 
Marshall Digital Scholar 
Management Faculty Research Management and Health Care Administration 
1-2018 





Follow this and additional works at: https://mds.marshall.edu/mgmt_faculty 
 Part of the Business Administration, Management, and Operations Commons, and the Health and 
Medical Administration Commons 
1 
 
THE IMPACT OF BIG DATA ON CHRONIC DISEASE MANAGEMENT 
ABSTRACT 
Introduction: Population health management – and specifically chronic disease management – 
depend on the ability of providers to identify patients at high risk of developing costly and harmful 
conditions such as diabetes, heart failure, and chronic kidney disease (CKD). The advent of big 
data analytics could help identify high-risk patients which is really beneficial to healthcare 
practitioners and patients to make informed decisions in a timelier manner with much more 
evidence in hand. It would allow doctors to extend effective treatment but also reduces the costs 
of extending improved care to patients. 
Purpose: The purpose of this study was to identify current applications of big data analytics in 
healthcare for chronic disease management and to determine its real-world effectiveness in 
improving patient outcomes and lessening financial burdens. 
Methodology: The methodology for this study was a literature review. Six electronic databases 
were utilized and a total of 49 articles were referenced for this research. 
Results: Improvement in diagnostic accuracy and risk prediction and reduction of hospital 
readmissions has resulted in significant decrease in health care cost. Big data analytic studies 
regarding care management and wellness programs have been largely positive. Also, Big data 
analytics guided better treatment leading to improved patient outcomes. 
Discussion/Conclusion: Big data analytics shows initial positive impact on quality of care, patient 
outcomes and finances, and could be successfully implemented in chronic disease management. 




Chronic diseases in the United States (U.S.) such as heart disease, stroke, cancer, Type 2 Diabetes 
Mellitus (T2DM), obesity, and chronic lung diseases have been the greatest preventable drivers of 
morbidity and mortality (Bauer, Briss, Goodman, & Bowman, 2014; CDC, 2014a). As of 2012, 
roughly 50% of the U.S. population (117 million people) had at least one chronic condition with 
25% suffering from more than one (Ward, 2014). In 2014, 7 of the top 10 causes of mortality in 
the U.S. were chronic diseases, with heart disease and cancer contributing to about 47% of deaths 
nationwide (NCHS, 2016). Although short-term improvements in preventable hospitalizations and 
cardiovascular deaths have been noted, there have been alarming increases in the rates of obesity 
(7.2% from 2013 to 2015) and self-reported diabetes (5.6% in the last 20 years) (CDC, 2014b; 
UHF, 2015). 
Apart from this morbidity and mortality burden, chronic medical illnesses accounted for 
86% of the U.S. healthcare expenditures in 2010. The total cost (direct medical plus lost 
productivity costs) to the U.S. was $315.4 billion for heart disease and stroke, $157.77 billion for 
cancer in 2010 and $345 billion for diabetes and prediabetes in 2012 (Mariotto, Yabroff, Shao, 
Feuer, & Brown, 2011; ADA, 2013; Go, et al., 2014). 
Population health management – and specifically chronic disease management – have 
depended on the ability of providers to identify patients at high risk of developing costly and 
harmful conditions such as diabetes, heart failure, and chronic kidney disease. These basic risk 
stratification tasks have been traditionally performed through non-electronic means, such as 
patient questionnaires, manual chart reviews, and in-person assessments (Bresnick, 2015). 
However, the advent of big data analytics has drastically changed the way providers can 
develop risk scores, monitor patients, and even divide cohorts into extremely narrow subgroups to 
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ensure precision care (Bates, Saria, Ohno-Machado, Shah, & Escobar, 2014). It has been envisaged 
that the ability to obtain and analyze big data could glean information that could identify high-risk 
individuals, inform more effective treatments, and pinpoint cost reduction areas across the 
healthcare system (Burg, 2014).  
Within healthcare, big data has been defined as high volume and high diversity biological, 
clinical, environmental, and lifestyle information collected from single individuals to large 
cohorts, in relation to their health and wellness status, at one or several time points (Auffray, et al., 
2016). Big data analytics has involved various analytical techniques ideal for analyzing a large 
proportion of text-based health documents and other unstructured clinical data (e.g., physician's 
written notes, prescriptions and medical imaging) such as descriptive, diagnostic, predictive, and 
prescriptive analytics (Groves, Kayyali, Knott, & VanKuiken, 2013). Predictive modelling has 
been noted to be vital to transforming large clinical datasets, or “big clinical data,” into actionable 
knowledge for various healthcare applications. Such models could guide clinical decision making 
and personalized medicine (Bauer, et al., 2014). For instance, asthma patients at high risk for 
hospitalization could be enrolled in an asthma case management program by determining their risk 
of hospitalization within the next year (Luo, Stone, Sakaguchi, Sheng, & Murtaugh, 2015).  
Furthermore, healthcare organizations must ensure the proper acquirement of tools, 
infrastructure, and techniques in order to best utilize big data to optimize their business and avoid 
risking losing millions in revenues and profits on useless data techniques (LaValle, Lesser, 
Shockley, Hopkins, & Kruschwitz, 2011). 
The reliance of U.S. healthcare system on big data has been anticipated to continue its 
climb to enable a more complete view with information on care coordination, outcomes-based 
reimbursement models, health management, and patient engagement (IHTT, 2013; Archenaa & 
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Anita, 2015). Massive datasets have been created in the medical field via the myriad data sources 
and electronic health records due to innovations. These innovations have included laparoscopic 
and robotic surgery, smart homes for patient self-monitoring, smart applications (apps) and 
softwares for body signal analysis and other mHealth technologies for biological, behavioral, and 
environmental data collection (Barbash & Glied, 2010; Peters & Buntrock, 2014; Theoharidou, 
Tsalis, & Gritzalis, 2014). 
Based upon early successes of big data, McKinsey and Company has estimated healthcare 
cost savings of 12% to 17% - $348 billion to $493 billion when extrapolated to healthcare expenses 
that reached $2.9 trillion in 2013 (Groves et al., 2013). Most of these savings were expected to 
come from clinical operations and Research and Development with $165 billion and $108 billion 
in waste, respectively (Manyika, et al., 2011). 
Overall, the purpose of this study was to identify current applications of big data analytics 
in healthcare for chronic disease management and to determine its real-world effectiveness in 
improving patient outcomes and lessening financial burdens. 
METHODOLOGY 
The conceptual framework for this research conformed to the steps and research framework 
followed by Yao, Chu and Li (2010). The framework elucidates the course of Big Data analytics 
adoption for chronic disease management. For an investigation into whether big data analytics can 
lead to improved patient outcomes in a cost-effective manner for people suffering from chronic 
diseases, their preliminary benefits and correspondent costs must be pinpointed at first. The 
process of technology adoption begins when problems in the existing system necessitate 
assessment of needs subsequently resulting in the creation and institution of a solution. It involves 
an evaluation of the benefits of and barriers to utilization of big data analytics once it is adopted, 
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and is repeated to permit appraisal of benefits and addressal of each of the barriers (see Figure 1). 
This conceptual framework is suitable for the present study as it centers on means of application 
of new technology in healthcare settings. Moreover, there is support for the internal validity of this 
approach evident from its successful replication in past studies (Coustasse, Tomblin, & Slack, 
2013; Deslich & Coustasse, 2014; Porterfield, Engelbert, & Coustasse, 2014).  
This study hypothesized that the introduction of Big Data Analytics for chronic condition 
management should demonstrate benefits in terms of improved diagnostic accuracy and risk 
prediction, more effective and targeted therapy along with reduced readmissions and expenses.  
This research utilized literature review as its methodology. The electronic databases of 
PubMed, Academic Search Premier, CINAHL Complete, ProQuest, EBSCOHost and Google 
Scholar were searched for the terms ‘Big data analytics’ or ‘Predictive analytics’ and ‘Chronic 
disease’ or ‘Chronic medical illness’. Articles were also retrieved from the American Diabetes 
Association and Centers for Disease Prevention and Control websites. Literature was selected to 
include the advantages of big data analytics for chronic disease management in regards to both 
outcomes and cost. To stay current in the research study, the search was limited to sources 
attainable as full texts published between 2007 and 2016 in the U.S. in English. Original articles, 
reviews and research studies including primary and secondary data were included. After a review 
of the abstracts, relevant articles were chosen. From a total of 90 references found, 49 resources 
were selected for this research. The literature search was conducted by A.S, B.W., N.B. and S.N. 
and validated by AC who acted as a second reader and double-checked that the references met the 
research study inclusion criteria. 
The results were categorized into the following subheadings: Big Data Analytics: 
Reduction of Readmissions, Big Data Analytics: Improvement in diagnostic accuracy and risk 
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prediction and Big Data Analytics: Treatment guidance, patient outcome improvement and 
financial implications. 
RESULTS 
As per a study conducted in 2015, 15% of providers have been using predictive modelling with 
92% of them utilizing the outputs to predict patient risk or illness. The illnesses and conditions 
most often targeted included: readmissions, patient deterioration, sepsis, and general patient health 
(CHIME, 2015). Per a study conducted by McKinsey and Company in 2013, more than 200 new 
businesses have developed innovative healthcare big data analysis apps since 2010 - 40% aimed 
at direct health interventions or predictive capabilities instead of apps formerly centered on data 
management and retrospective data analysis (Kayyali, Knott, & VanKuiken, 2013). (See Figure 
2). Table 1 lists the study design and purpose and summarizes the findings of the studies included 
in this review. 
Big Data Analytics: Reduction of Readmissions 
Hospital readmissions are an important quality indicator for health systems, being a 
significant contributor to health care costs (Parikh, Kakad, & Bates, 2016). All-cause 30-day 
readmissions cost the US hospitals more than $41.3 billion in 2011 (Hines, Barrett, Jiang, & 
Steiner, 2011). While studying the 30-day risk of readmission for congestive heart failure patients 
using predictive analytics on more than 3 million patient records, Zolfaghar, et al., (2013), reported 
an accuracy of 77% and recall of 61%. Parkland Health and Hospital System, Dallas, TX, utilized 
Electronic Medical Record data to predict readmission risk for heart failure patients and noticed 
26% relative reduction in risk-adjusted odds of readmission among patients enrolled post 
intervention versus those enrolled pre-intervention (Amarasingham, et al., 2013). In another study, 
7 
 
a model predicting risk of rehospitalization within 30 days utilizing 15 years of medical data was 
seen to have a positive predictive value of 54% (Hoch & Karpati, 2013). (See Table 1). 
Big Data Analytics: Improvement in Diagnostic Accuracy and Risk Prediction 
Ross, Shah, Dalman, Nead, & Leeper (2016) showed that use of machine learning based 
predictive analytics provided better results than the gold standard risk prediction scores for 
identifying undiagnosed Peripheral Arterial Disease (PAD) (Machine learning - 84%; PAD risk 
score - 71%) and predicting future risk of major adverse cardiac events (Machine learning - 70%, 
Framingham score - 56%). Another study by Rusin, et al., (2016) used continuous high resolution 
recordings to measure the effectiveness of automated, intelligent analysis of standard physiologic 
data in real-time to detect signs of clinical deterioration too subtle to observe for clinicians in 
children with parallel systemic and pulmonary circulation (such as hypoplastic left heart 
syndrome) reported that the algorithm was 91% accurate for detecting impending events and could 
possibly serve as an early warning indicator for such patients. (See Table 1). 
Razavian, et al., (2015) mentioned that applying a population-level risk prediction model 
for T2DM on readily available administrative data improved positive predictive value by at least 
50% in predicting diabetes when compared to classical diabetes risk prediction algorithms on very 
large populations with inadequate data. It also identified novel risk factors for T2DM, such as 
chronic liver disease (Odds Ratio [OR] 3.71), high alanine aminotransferase (OR 2.26), esophageal 
reflux (OR 1.85), and history of acute bronchitis (OR 1.45). Kupersmith, et al., (2007) analyzed 
the U.S. Veterans Health Administration’s EHR data to identify a high rate of mental illness 
comorbidity (24.5%) among patients with diabetes by exploring the influence of surrogate 
attributes. (See Table 1). 
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A retrospective analysis of big data stored within Optum Labs data warehouse by McCoy, 
et al., (2016) indicated that intensive treatment almost doubled severe hypoglycemia risk among 
complicated patient cases. Data Mining Algorithms were applied to a large clinical dataset and an 
increase in T2DM classification accuracy was noticed from 78.71% to 86.64% for Hemoglobin 
A1C (HbA1c) at 6.5% if an oxidative stress marker was included in the algorithm and to 85.63% 
when interleukin-6 was included but with lower optimal HbA1c range between 5.73 and 6.22% 
(Jelinek, Stranieri, Yatsko, & Venkatraman, 2016).  (See Table 1). 
Using Explorys, a novel big data storage system - it was observed that patients with nicotine 
dependence, obesity, depressive disorders, and alcohol abuse had a relative risk of 4.489, 6.007, 
5.511, and 3.326 for low back pain, respectively, compared to patients without it. (Shemory, 
Pfefferle, & Gradisar, 2016). Van Fossen, Wilhelm, Eaton, & McHenry, (2013) also utilized 
Explorys and reported an increase in prevalence of subsequent breast and renal cell cancer in 
thyroid cancer patients (female: 0.67- and two-fold; M - 29- and 4.5-fold respectively) and of 
thyroid cancer in breast and renal cell cancer patients (Female: twofold and 1.5-fold; Male - 19- 
and threefold respectively). (See Table 1). 
Dinov, et al., (2016) explored risk of Parkinson’s disease utilizing the Parkinson's 
Progression Markers Initiatives’ (PPMI) unique archive containing complex imaging, genetics, 
clinical and demographic data. It was found that model-free Big Data machine learning-based 
classification methods were significantly powerful in predicting Parkinson's disease in the PPMI 
subjects with an accuracy, sensitivity, and specificity consistently exceeding 96%. The Cleveland 
Clinic developed dashboards for their care managers that utilized patient data from EHR and excel 
sheets to pinpoint about 1,000 out of 54000 local, at high risk patients not currently covered by 
care coordination by using filters based on geography, condition and many more. These patients 
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could then be engaged, have appointments fixed and their medication adherence monitored (Health 
Data Management, 2016). (See Table 1). 
Big Data Analytics: Treatment Guidance, Patient Outcome Improvement and Financial 
Implications 
Big data analytic studies of care management and wellness programs have been largely 
positive. For example, per Berg (2015), number of members that would have had an asthma 
controller medication prescription decreased by 7.3% and those with a prescription for statin 
medication decreased by 16.6% without the care management program (Berg, 2015). In another 
study, Chronic Obstructive Pulmonary Disease (COPD) patients at risk for exacerbation were 
identified using big data from the HealthCore Integrated Research Environment and followed for 
12 months. COPD exacerbation risk was reduced by 22% with lower COPD-related healthcare 
resource utilization and costs of $4,084 vs $5,656 per patient-year in association with the initiation 
of budesonide/formoterol combination versus tiotropium, respectively, was noticed (Trudo, et al., 
2015). Propeller Health, a leading digital platform for respiratory health management, has used 
sensors for asthma inhalers, along with mobile apps and advanced analytics on big data, to help 
providers identify at-risk asthma patients before an attack occurs. During a 12-month study that 
measured real-world effectiveness of this platform to reduce use of Short Acting Beta Agonists 
(SABA) and improve asthma control, the study arm monitoring SABA use with the Propeller 
Health system significantly decreased SABA used (daily mean number of SABA users 0.41 vs 
0.31), increased SABA-free days (21% vs 17%), and improved asthma control test scores (63% vs 
49%) (Merchant, Inamdar, & Quade, 2016). (See Table 1). 
The EMR data from the Nihon University School of Medicine clinical big data warehouse 
has been used for several retrospective analysis studies. One study found an increase in the risk of 
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gastrointestinal bleeding associated with a combination of clopidogrel and aspirin versus aspirin 
alone (RR - 2.06) for stroke risk reduction (Takahashi, Nishida, Nakayama, & Asai, 2013). 
Nishida, et al., (2013) found losartan had a beneficial effect on serum uric acid levels (decrease of 
0.14 mg/dl) compared to an increase caused by other angiotensin receptor blockers in hypertensive 
T2DM patients. (See Table 1). 
DISCUSSION 
This literature review aimed to look for signs that big data analytics could prove beneficial for 
chronic disease management and ultimately lead to improved outcomes, reduced disease burden 
and decrease treatment costs. Improving outcomes for patients suffering from chronic diseases 
should begin with gaining an understanding of the disease epidemiology from the massive pool of 
data through appropriate application of big data analytics. Determination of treatable patient risk 
factors and risk for readmission will help providers identify and monitor at-risk patients to prevent 
and manage chronic disease more effectively. 
The publications included in our review applied analytics to gain insights such as risk 
predictions for diseases like diabetes, cancer, heart disease, low back pain and prediction of re-
hospitalization/readmission risk and to provide information to enable readmission reduction and 
treatment guidance for diseases like hypertension, diabetes, stroke. Also, the studies that predicted 
risk of disease or diagnosed diseases all had an accuracy rate exceeding 70%. This could be applied 
to detect undiagnosed cases of chronic disease before they become too severe. 
In a paper, Raghupathi & Raghupathi (2014) concluded that the field of big data analytics 
has shown potential for extracting insight from enormous data sets and improving outcomes while 
minimizing costs. The results from this literature review concur with their conclusions. There is 
consistent evidence that big data analytics can improve patient outcome, enhance diagnostic 
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accuracy and reduce costs, thus, demonstrating potential benefits for its use for chronic disease 
management. 
This literature review had a number of limitations. To begin with, there is a scarcity of 
quality big data sources even after EHR implementation for data analysis. Also, the initial cost of 
conducting big data analytics currently limits its use to large academic hospitals. Thus, there were 
a small number of articles demonstrating real-world application & benefits of big data analytics.  
Further, some of the studies applied analytics only to gain deeper understanding of the chronic 
disease without reporting a positive effect on patient outcomes. Additionally, as articles were 
evaluated to establish relevancy, publication and researcher bias cannot be ruled out. 
All stakeholders in healthcare including healthcare organizations, payers, physicians, and 
patients have much to gain from implementation of big data analytics for chronic disease 
management. It can help monitor clinical indicators for decision support and explore which 
treatment option is most likely to result in clinical improvements for patients, thereby, reducing 
readmissions and improving quality of care/outcomes. Ultimately, it may lead to substantial 
savings for healthcare facilities. In order to realize these rewards, an increase in the support and 
investment into such a system must be considered. Many hospitals and health systems may already 
have an existing data source such as DW. Yet, these have not been utilized to their full capacity. 
With employment of big data analytics, full benefits realization can be achieved.  
CONCLUSION 
Big data analytics seem to have a positive impact on chronic disease care. Despite concerns of 
implementation costs and efficacy of data analysis, hospitals and other chronic care settings have 
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seen promising initial results in terms of improvement in clinical outcomes as well as financial 
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Key: 100% = 132 
Source: 2010-11 submissions to Health Data Initiative Forum; Rock Health; Standard & Poor’s 
Capital IQ; McKinsey analysis. 







Table 1: Big Data Analytics – By Study Design, Purpose and Study Findings 
Author Study Design Purpose Findings 
Kupersmith, et al., 
2007 
Retrospective (cohort) Risk prediction for 
diabetic patients 
Rate of mental illness 
comorbidities 
associated with 
diabetes - 24.5% 







Relative reduction in 
risk-adjusted odds of 
readmission in the IG 
vs CG- 26% 
Van Fossen,  et al., 
2013 
Cohort study Risk prediction for 




Subsequent breast and 
renal cell cancer in 
thyroid cancer 
patients: Female: 
0.67- and two-fold, 
Male: 29- and 4.5-
fold  
Subsequent thyroid 
cancer in breast and 
renal cell cancer 
patients: Female: 
twofold and 1.5-fold, 
Male: 19- and 
threefold 
Hoch & Karpati, 2013 Retrospective study Risk prediction for 
rehospitalization 
within 30 days 
Positive predictive 
value: 54% 





Change in serum uric 














for patients at high-
risk for stroke 
Relative risk of 
gastrointestinal 
bleeding with use of 
clopidogrel + aspirin 




Zolfaghar, et al., 2013 Retrospective study Prediction of 




Berg, 2015 N/A Improvement in 
patient outcomes for 
asthmatic and high 
cholesterol patients 
Increase in number of 
members that 
received prescription 
for - asthma 
controller: 7.3%; 
statin: 16.6% 
Razavian, et al., 2015 Retrospective study Improvement in 




value ≥ 50% over 
classical algorithms 
Trudo, et al., 2015 
 
Retrospective study Improvement in 
patient outcomes and 
reduction in costs for 
COPD patients 
Decrease in risk of 








Dinov, et al., 2016 Prospective cohort Diagnosis of 
Parkinson’s disease 
Accuracy, sensitivity, 
and specificity > 96% 
25 
 
Jelinek, et al., 2016 Prospective study Improvement in risk 
prediction for diabetic 
patients 




inclusion in algorithm 
- 78.71% to 86.64% 
for HbA1C at 6.5%; 
Interleukin-6 - 
78.71% to 85.63% 
with HbA1c range 
between 5.73% and 
6.22% 
McCoy, et al., 2016 Retrospective data 
analysis 




vs standard): Low 
clinical complexity: 





Merchant, et al., 2016 Pragmatic controlled 
study 
Improvement in 
patient outcomes in 
asthmatic patients 
Decrease in SABA 
use - IG: 0.41; CG: 
0.31 
Increase in SABA-
free days - IG: 21%; 
CG: 17% 
Improvement in ACT 
scores - IG: 63%; CG: 
49% 




diagnostic accuracy of 
undiagnosed PAD and 
risk prediction for 
future major adverse 
cardiac events 
Accuracy of PAD 
prediction: MLPA: 
84%, PAD Risk 
Score: 71%; Future 







Rusin, et al., 2016 Cross-sectional study Risk prediction for 




Shemory, et al., 2016 Prospective cohort 
study 
Risk prediction for 




4.489, Obesity: 6.007, 
Depressive disorders: 
5.511, Alcohol abuse: 
3.326 
Key: IG=Intervention Group, CG=Control Group, BFC=Budesonide/Formoterol Combination, 
SABA=Short Acting Beta Agonists, CHF=Congestive Heart Failure, COPD=Chronic 
Obstructive Pulmonary Disease, ACT=Asthma Control Test, PAD=Peripheral Arterial Disease, 
AUC=Area Under Curve, MLPA=Machine Learning based Predictive Analytics, N/A=Not 
Applicable 
 
 
 
 
